SYNANTHIC 22.5% SUSPENSION DIN 01913379
Health Canada record
| Active ingredient(s) | OXFENDAZOLE 22.5 % |
|---|---|
| Dosage form | Suspension |
| Route | Intraruminal; Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1991 |
| Current status date | 12-Aug-2002 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OXFENDAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00592307 | BENZELMIN EQUINE ANTHELMINTIC ORAL PASTE 37.5% | AYERST VETERINARY LABORATORIES | Paste | OXFENDAZOLE 37.5 % | Cancelled Post Market |
| 02231772 | BENZELMIN EQUINE ANTHELMINTIC ORAL SUSPENSION | AYERST VETERINARY LABORATORIES | Suspension | OXFENDAZOLE 9.06 % | Cancelled Post Market |
| 00598895 | BENZELMIN SUSPENSION 90.6MG/ML | SYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC. | Suspension | OXFENDAZOLE 90.6 MG | Cancelled Post Market |
| 02012480 | SYNANTHIC SUSPENSION 9.06% | SYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC. | Suspension | OXFENDAZOLE 90.6 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6178 | 2001-10-09 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6928 | 1998-10-01 | New Drug Submission (NDS) | |
| 6929 | 1998-10-01 | Supplement to a New Drug Submission (SNDS) | TO PROVIDE FOR ORAL ADMINISTRATION IN CATTLE |